Rite Aid (NYSE:RAD) updated its first quarter 2022 earnings guidance on Tuesday. The company provided EPS guidance of – for the period. The company issued revenue guidance of $6.10 billion-$6.30 billion, compared to the consensus revenue estimate of $6.05 billion.
RAD has been the topic of several research reports. Zacks Investment Research cut shares of Rite Aid from a buy rating to a hold rating and set a $25.00 target price on the stock. in a report on Wednesday, February 17th. TheStreet upgraded Rite Aid from a d+ rating to a c- rating in a research note on Monday, February 8th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Rite Aid from $17.00 to $27.00 and gave the company a hold rating in a research report on Thursday, March 25th. One analyst has rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. The stock currently has an average rating of Hold and an average price target of $18.75.
Shares of NYSE:RAD traded down $0.41 during midday trading on Tuesday, hitting $17.53. The company had a trading volume of 2,241,059 shares, compared to its average volume of 2,573,984. The company has a debt-to-equity ratio of 5.27, a current ratio of 1.49 and a quick ratio of 0.75. The company has a fifty day moving average of $20.45 and a two-hundred day moving average of $17.99. The company has a market cap of $965.94 million, a price-to-earnings ratio of -2.41 and a beta of 1.01. Rite Aid has a 12-month low of $8.85 and a 12-month high of $32.48.
Rite Aid Company Profile
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Featured Article: Portfolio Manager
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.